Hedge Fund - Parkman Healthcare Partners
Neurocrine Biosciences Inc (NBIX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $16,269,603 | 1.55% | 114,712 | $144.87 |
| 2 | 2025 - Q3 (2025-09-30) | $19,908,972 | 2.08% | 141,822 | $135.50 |
| 3 | 2025 - Q2 (2025-06-30) | $20,865,797 | 2.4% | 166,010 | $114.68 |
| 4 | 2025 - Q1 (2025-03-31) | $18,623,049 | 2.21% | 168,382 | $126.68 |
| 5 | 2024 - Q4 (2024-12-31) | $15,796,736 | 2.1% | 115,727 | $123.68 |
| 6 | 2024 - Q3 (2024-09-30) | $14,960,165 | 1.9% | 129,840 | $137.09 |
| 7 | 2024 - Q2 (2024-06-30) | $15,855,454 | 2.12% | 115,170 | $137.14 |
| 8 | 2024 - Q1 (2024-03-31) | $18,198,682 | 2.23% | 131,951 | $136.57 |
| 9 | 2023 - Q4 (2023-12-31) | $18,461,684 | 2.6% | 140,116 | $115.11 |
| 10 | 2023 - Q3 (2023-09-30) | $9,432,563 | 1.72% | 83,845 | $105.30 |
| 11 | 2023 - Q2 (2023-06-30) | $13,177,011 | 2.28% | 139,735 | $97.71 |
| 12 | 2023 - Q1 (2023-03-31) | $22,049,562 | 4.79% | 217,838 | $104.06 |
| 13 | 2022 - Q4 (2022-12-31) | $13,894,814 | 3.69% | 116,333 | $117.13 |
| 14 | 2022 - Q3 (2022-09-30) | $12,469,000 | 3.54% | 117,400 | $101.46 |
| 15 | 2022 - Q2 (2022-06-30) | $8,343,000 | 3.07% | 85,589 | $92.29 |
| 16 | 2022 - Q1 (2022-03-31) | $5,928,000 | 1.73% | 63,234 | $84.75 |
| 17 | 2020 - Q4 (2020-12-31) | $0 | 0% | 0 | $96.59 |
| 18 | 2020 - Q3 (2020-09-30) | $12,745,000 | 3.37% | 132,544 | $115.68 |
| 19 | 2020 - Q2 (2020-06-30) | $14,826,000 | 4.17% | 121,526 | $110.51 |
| 20 | 2020 - Q1 (2020-03-31) | $11,124,000 | 5.15% | 128,526 | $97.87 |
| 21 | 2019 - Q4 (2019-12-31) | $16,707,000 | 4.82% | 155,425 | $104.70 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center